Abstract: A method of synthesizing colloidal semiconductor-metal hybrid heterostructures is disclosed. The method includes dissolving semiconductor nanorods in a solvent to form a nanorod solution, and adding a precursor solution to the nanorod solution. The precursor solution contains a metal. The method further includes illuminating the combined precursor and nanorod solutions with light of a specific wavelength. The illumination causes the deposition of the metal in the precursor solution onto the surface of the semiconductor nanorods.

Abstract: A cyclophosphazene compound of the formula (I), and lubricants and magnetic disks using the compound wherein n is 2, 3 or 4, m is an integer of 1 to 12, R is C1-4 fluoroalkyl and Rf is —CF2O(CF2CF2O)x(CF2O)yCF2— or —CF2CF2O(CF2CF2CF2O)zCF2CF2— in which x, y and z are each 0 or a positive real number to give a number average molecular weight of 500 to 4000 to a fluoropolyether of the formula HOCH2—Rf—CH2OH including said Rf, the fluoropolyether having a molecular weight distribution (PD) of 1.0 to 1.5.

Abstract: The present invention relates to electronic devices, in particular organic electroluminescent devices, which comprise compounds of the formula (1), and to the corresponding compounds and to the use thereof in organic electroluminescent devices.

Abstract: An organic light-emitting diode comprising at least one cyclic phosphazene compound, a light-emitting layer formed from at least one matrix material and at least one emitter material, wherein the at least one matrix material comprises at least one cyclic phosphazene compound, the use of cyclic phosphazene compounds in organic light-emitting diodes and a device selected from the group consisting of stationary visual display units, mobile visual display units and illumination units comprising at least one inventive organic light-emitting diode, and selected cyclic phosphazene compounds and processes for preparing them.

Abstract: Compounds of formula I: wherein X are independently —(CH2)b—, wherein b is 0 or an integer from 1 to 6; Rf are independently —CF2O(CF2CF2O)p(CF2)qCF2—, —CF2CF2O(CF2CF2CF2O)rCF2CF2—, or —CF2CF2CF2O(CF2CF2CF2CF2O)sCF2CF2CF2—, or derivatives thereof, wherein p, q, r and s are independently integers so that Mn of Rf is about 150 to 4500; and Z are independently chosen from groups that comprise —OH, —(OH)2, —COOCH3, —F, —CF3, or —CF2CF3, with the caveat that not all Z are the same.

Abstract: The present invention relates to a method for purifying a crude PNPNH compound by metalation and re-protonation.

Abstract: The present invention provides a nonaqueous electrolyte solution, which can improve flame retardancy and ameliorate performances of a battery without deteriorating the basic battery performance as far as possible, and a secondary battery. The nonaqueous electrolyte solution is a nonaqueous electrolyte solution for a secondary battery that contains metal salts including ions of metals belonging to group 1 or 2 of the periodic table and a specific cyclic compound having phosphorus and nitrogen atoms in a non-protonic solvent. The non-protonic solvent is a solvent that contains at least one kind of carboxylic acid ester compound and carbonic acid ester compound, and a ratio (MPN/Ms) between a mass (Ms) of the non-protonic solvent containing the metal salts and a mass (MPN) of the cyclic compound is 0.01 to 1.

Abstract: Processes for the treatment of an aqueous mixture comprising a dipolar aprotic compound, comprise: a) an adsorption step, in which the aqueous mixture is brought into contact with a porous adsorbent, whereby the porous adsorbent is chosen such that the dipolar aprotic compound adsorbs to it more readily than water; b) a desorption step, in which the porous adsorbent is brought into contact with a desorbing agent, whereby a recovery solution is formed comprising the desorbing agent and the dipolar aprotic compound.

Abstract: The present invention relates to a 1,4,2-diazaphospholidine of the formula (1) wherein R1, R2 represent, independently of one another, saturated or mono- or polyunsaturated C1-C20-alkyl, -alkenyl, -alkynyl or C5-C40-aryl groups optionally substituted or interrupted by at least one heteroatom selected from the group consisting of N, O, S, and halogen, and X represents identical or different substituents selected from the group consisting of O, S, and N—R2.

Abstract: This invention discloses a solvent-free process for the preparation of cyclophosphamide. According to this invention, there is no solvent used during the reaction step for preparing cyclophosphamide, so that the total volume of the reaction for preparing cyclophosphamide can be reduced and the manufacture of cyclophosphamide can become more efficient. Furthermore, the above solvent-free process for the preparation of cyclophosphamide is more simply operated, more economic, and more environmental friendly than the preparation of cyclophosphamide in the prior art.

Abstract: A compound of the formula (1), lubricant containing the compound and magnetic disk (P3N3)—[R1-R2]6??(1) wherein R1 is —OCH2CF2O(CF2CF2O)x(CF2O)yCF2CH2O—, or —OCH2CF2CF2O(CF2CF2CF2O)ZCF2CH2O— or —OCH2CF2CF2CF2O(CF2CF2CF2CF2O)nCF2CF2CF2CH2O—, x and y are each an integer of 0 to 15, z is an integer of 1 to 15, n is an integer of 0 to 20, R2 is hydrogen, hydroxyalkyl, amino or amido.

Abstract: The present invention relates to a non-aqueous electrolyte additive that allows for improved safety and battery characteristics of a non-aqueous electrolyte secondary battery, and in greater detail, the present invention relates to a non-aqueous electrolyte additive that includes a phosphazene compound represented by the following general formula (1): (NPR2)n ??(1) wherein each R independently represents fluorine or a secondary or tertiary branched alkoxy group substituted with fluorine, at least one of the Rs represents the secondary or tertiary branched alkoxy group substituted with fluorine, and n is from 3 to 14.

Abstract: The invention provides a polycyclic aromatic compound or a salt thereof having a partial structure represented by the following general formula (I): wherein X, ring A, ring B, ring C, and ring D are as defined in the specification.

Abstract: An additive comprising a phosphazene compound that has at least two reactive functional groups and at least one capping functional group bonded to phosphorus atoms of the phosphazene compound. One of the at least two reactive functional groups is configured to react with cellulose and the other of the at least two reactive functional groups is configured to react with a resin, such as an amine resin or a polycarboxylic acid resin. The at least one capping functional group is selected from the group consisting of a short chain ether group, an alkoxy group, and an aryloxy group. Also disclosed are an additive-resin admixture, a method of treating a wood product, and a wood product.

Abstract: Phosphazenium-based ionomers and methods of making them are disclosed. The ionomers are useful in making membranes for fuel cells and other devices that benefit from extremely base-stable membranes. The polymers (ionomers) contain repeating units of formula: in which all of R1, R2, W, Y and Z are hydrocarbon.

Abstract: An electrolyte additive and electrolyte and lithium rechargeable battery including the electrolyte additive are provided. The electrolyte additive may be a monosubstituted pentafluorocyclotriphosphazene.

Abstract: Compounds of formula I: wherein X are independently —(CH2)b—, wherein b is 0 or an integer from 1 to 6; Rf are independently —CF2O(CF2CF2O)p(CF2)qCF2—, —CF2CF2O(CF2CF2CF2O)rCF2CF2—, or —CF2CF2CF2O(CF2CF2CF2CF2O)sCF2CF2CF2—, or derivatives thereof, wherein p, q, r and s are independently integers so that Mn of Rf is about 150 to 4500; and Z are independently chosen from groups that comprise —OH, —(OH)2, —COOCH3, —F, —CF3, or —CF2CF3, with the caveat that not all Z are the same.

Abstract: A phosphorous flame retardant primarily includes hexachlorotriphosphazene (HCP) having poly(oxyalkylene)amine substitutes. The poly(oxyalkylene)amine includes at least two end groups. The phosphorous flame retardant can further include layered silicate clay. The layered silicate clay can be intercalated and modified with the poly(oxyalkylene)amine substitutes of HCP to effectively promote thermal stability. The flame retardant, phosphazene-poly(oxyalkylene)amine adducts, can be applied to a polymer. By the cross-linking between them, the flame-retarding property of the polymer can be improved. Also provided is a method for producing the flame retardant of phosphazene-poly(oxyalkylene)amine adducts and application thereof to a polymer.

Abstract: A chiral tetraaminophosphonium salt represented by formula (1) and a method for producing chiral ?-nitroalcohol comprising reacting an aldehyde or a ketone and a nitroalkane in the presence of the chiral tetraaminophosphonium salt represented by formula (1) and a base, or in the presence of a conjugated base of the chiral tetraaminophosphonium salt represented by formula (1): wherein R1 to R4 are independently a hydrogen atom or a monovalent hydrocarbon group; and, R1 and R2 are different groups or R3 and R4 are different groups.

Abstract: The present invention relates to electronic devices, in particular organic electroluminescent devices, which comprise compounds of the formula (1) or (2), and to the corresponding compounds and to the use thereof in organic electroluminescent devices.

Abstract: The present invention is to provide means to treat breast cancer and/or mastitis by topically administering a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent and allowing them efficiently to arrive into the mammary gland. The present invention provides an iontophoretic preparation for treating breast cancer and/or mastitis which contains a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent as an active ingredient and has a donor to be applied on a nipple part for topical administration of the active ingredient from the nipple part to the mammary gland by application of electric potential.

Abstract: Compositions for use in lubricating thin film storage media are provided, as well as storage media formed using the compositions, the compositions including one or more central cores having a cyclic group, and a plurality of arms extending from the central cores, wherein each arm comprises phenol or piperonyl. Methods of preparing the compositions are also provided. Methods of preparing storage media that incorporate the compositions therein are further provided.

Abstract: An ion transporting solvent for use with batteries can be improved by simultaneously shortening a phosphazene compound's pendent groups, eliminating most or all of the distal ion carriers, and randomizing the solvent molecules so as to intentionally disrupt symmetry to the maximum degree possible. The combination of these strategies dramatically improves battery performance to the point where the performance recorded is comparable to batteries using conventional organic solvents.

Abstract: An additive comprising a phosphazene compound that has at least two reactive functional groups and at least one capping functional group bonded to phosphorus atoms of the phosphazene compound. One of the at least two reactive functional groups is configured to react with cellulose and the other of the at least two reactive functional groups is configured to react with a resin, such as an amine resin or a polycarboxylic acid resin. The at least one capping functional group is selected from the group consisting of a short chain ether group, an alkoxy group, and an aryloxy group. Also disclosed are an additive-resin admixture, a method of treating a wood product, and a wood product.

Abstract: Disclosed is a phosphazene compound and a photosensitive resin composition. The phosphazene compound is obtained by reacting a phenoxyphosphazene compound (A-1) having a phenolic hydroxyl group and/or a cross-linked phenoxyphosphazene compound (A-2) obtained by cross-linking the phenoxyphosphazene compound (A-1) with an epoxy compound (B) having an unsaturated double bond and/or an isocyanate compound (C), wherein the phosphazene compound has an unsaturated double bond in its molecule.

Abstract: The disclosure includes hydroxamic compounds of Formula I: (I) wherein P, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.

Abstract: The present invention is to provide means to treat breast cancer and/or mastitis by topically administering a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent and allowing them efficiently to arrive into the mammary gland. The present invention provides an iontophoretic preparation for treating breast cancer and/or mastitis which contains a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent as an active ingredient and has a donor to be applied on a nipple part for topical administration of the active ingredient from the nipple part to the mammary gland by application of electric potential.

Abstract: The present invention relates to electronic devices, in particular organic electroluminescent devices, which comprise compounds of the formula (1), and to the corresponding compounds and to the use thereof in organic electroluminescent devices.

Abstract: An organic light-emitting diode comprising at least one cyclic phosphazene compound, a light-emitting layer formed from at least one matrix material and at least one emitter material, wherein the at least one matrix material comprises at least one cyclic phosphazene compound, the use of cyclic phosphazene compounds in organic light-emitting diodes and a device selected from the group consisting of stationary visual display units, mobile visual display units and illumination units comprising at least one inventive organic light-emitting diode, and selected cyclic phosphazene compounds and processes for preparing them.

Abstract: Described herein are methods for treating neurological autoimmune disorders in which the treatment method includes administering an immunoablative agent to eliminate most or essentially all maturing and mature elements of the immune system in an affected individual. Following this step, the individual is administered agents to reestablish the ablated immune system.

Abstract: A method of lubricating a wind turbine gearbox comprising using a lubricating composition comprising at least one (i.e. one or a mixture of more than one) perfluoropolyether (PFPE) lubricant which comprises a perfluorooxyalkylene chain, said perfluorooxyalkylene chain comprising recurring units having at least one ether bond and at least one fluorocarbon moiety. A wind turbine gearbox comprising a lubricating system containing said lubricating composition.

Abstract: The present invention provides an agent that modulates physiological condition of pests, wherein the agent has an ability to modulate the activity of an insect c-Jun NH2-terminal kinase; a method for assaying pesticidal activity of a test substance, which comprises a step of measuring the activity of a c-Jun NH2-terminal kinase in a reaction system in which the c-Jun NH2-terminal kinase contacts with a test substance, and the like.

Abstract: A phosphazene compound, which can effectively enhance flame retardancy without deteriorating mechanical properties of a resin molded product, and is also less likely to deteriorate thermal reliability and dielectric properties, is represented by the formula (1) shown below. n represents an integer of 3 to 15. wherein A represents a group selected from the group consisting of an alkoxy group, an aryloxy group and a group having a cyanato group, and at least one is a group having a cyanato group, and an example of A is a cyanatophenyl-substituted phenyloxy group represented by the formula (4) shown below, and Y in the formula (4) represents O, S, SO2, CH2, CHCH3, C(CH3)2, C(CF3)2, C(CH3)CH2CH3 or CO.

Abstract: This application relates to the design and synthesis of new chiral imines reagents which can be utilized for the synthesis of chiral drugs and their precursors. It describes the design of the free NH2-group-attached chiral phosphoramides, a chiral N-phosphonimines and the methods for forming the same. The free NH2-group-attached chiral phosphoramides, having the structure of formula (I): wherein R1 and R2 are independently any organic groups. The synthesis of N-phosphoramides was performed starting from chiral 1,2-diamines via the following steps: N,N?-dialkylation consisting of aldehyde condensation and reduction, cyclization with phosphoryl halide, substitution of halide with azide anion and hydrogenation of azides. The N-phosphonyl imines are synthesized by condensation of N-phosphoramides with aldehydes. Quantitative yield was obtained for each of the four steps without special purification. All precursors were obtained as white solids.

Abstract: A compound of the formula (I), and lubricant, and magnetic disk each using the same A-(CH2—Rf—CH2O—B—O)n—CH2—Rf—CH2-A??(I) wherein n is an integer of 1 to 4, A is a group of the formula (a) below, and B is a group of the formula (b) below, p being 1 or 2, R being C1-4 fluoroalkyl, Rf is —CF2O(CF2CF2O)x(CF2O)yCF2— or —CF2CF2O(CF2CF2CF2O)nCF2CF2—, x, y and z being each a real number of 0 to 50.

Abstract: This invention relates to a novel ionic compound being low in a risk of combustion, and more particularly to an ionic compound represented by the following formula (I): (NPR12)n ??(I) [wherein R1s are each independently a halogen element or a monovalent substituent, provided that at least one of R1s is an ionic substituent represented by the following general formula (II): —N+R23X???(II) (wherein R2s are independently a monovalent substituent or hydrogen, provided that at least one of R2s is not hydrogen and R2s may be bonded with each other to form a ring; and X? is a monovalent anion); and n is 3 to 15].

Abstract: Disclosed are compounds of formulae (I), (III), (IV), (VII), (X), (XI), (XII), (XIII) and (XIV), wherein the variabables are as defined in the claims, and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.

Abstract: A compound of the formula: (I) is provided, where R is selected from CF3, F, and H, and m is an integer from 1 to 22. The compound may be prepared by reacting a first reactant with a second reactant in a solution, where the first reactant is a 2,4-dichloro-2,4,6,6-tetra(aryloxy)-1,3,5-triaza-2,4,6-triphosphorine, and the second reactant is a perfluoropolyether of the formula CF3CF2CF2O(CF2CF2CF2O)mCF2CF2CH2OH. The aryloxy is selected from 4-(trifluoromethyl)phenoxy (p-CF3—C6H4O), 4-fluorophenoxy (p-F—C6H4O), and phenoxy (C6H5O). The first reactant may be prepared by reacting 2,2,4,4,6,6-hexachloro-1,3,5-triaza-2,4,6-triphosphorine with a phenoxide. The compound may be used in a lubricant for lubricating a surface. The lubricant may be applied to a recording surface in a magnetic recording device including a recording medium.

Abstract: The present invention is to provide means to treat breast cancer and/or mastitis by topically administering a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent and allowing them efficiently to arrive into the mammary gland. The present invention provides an iontophoretic preparation for treating breast cancer and/or mastitis which contains a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent as an active ingredient and has a donor to be applied on a nipple part for topical administration of the active ingredient from the nipple part to the mammary gland by application of electric potential.

Abstract: A lyophilized unit dose form containing about 2 g of glufosfamide is useful in treatment of cancer and other hyper-proliferative diseases.

Abstract: A cyclic phosphazene compound complying with formula (I) or (II): wherein: Rf and R?f represent independently a (per)fluoropolyoxyalkylene chain comprising recurring units Ro, said recurring units, distributed randomly through the (per)fluoropolyoxyalkylene chain, being chosen among; (i)—CFXO—, X being F or CF3; (ii) —CF2CFXO—, X being F or CF3; (iii) —CF2CF2CF2O—; (iv) —CF2CF2CF2CF2O—; Z and Z? represent a polar group of formula —O?M+, M being chosen among hydrogen, a monovalent metal, or an ammonium radical of formula NR1R2R3R4, or represent a polar group of formula —O?)2M?2+, M? being a divalent metal; nZ is an integer from 1 to 3; nZ? is an integer from 1 to 4; nf? is an integer such that nZ?+nf? is equal to 8; and nf is an integer such that nZ+nf is equal to 6.

Abstract: The present invention relates to new oxazaphosphorine alkylating agents and/or immuno-suppressive agents, pharmaceutical compositions thereof, and methods of use thereof.

Abstract: A phosphazene compound, which can effectively enhance flame retardancy without deteriorating mechanical properties of a resin molded product, and is also less likely to deteriorate thermal reliability and dielectric properties, is represented by the formula (1) shown below. n represents an integer of 3 to 15. wherein A represents a group selected from the group consisting of an alkoxy group, an aryloxy group and a group having a cyanato group, and at least one is a group having a cyanato group, and an example of A is a cyanatophenyl-substituted phenyloxy group represented by the formula (4) shown below, and Y in the formula (4) represents O, S, SO2, CH2, CHCH3, C(CH3)2, C(CF3)2, C(CH3)CH2CH3 or CO.

Abstract: Methods and compounds are provided for the formation of carbon-nitrogen or carbon-carbon bonds comprising reacting an amine or an aryl boronic acid with an aryl halide in the presence of a palladium catalyst, a base, and a compound of formula II:

Abstract: A chiral tetraaminophosphonium salt represented by formula (1) and a method for producing chiral ?-nitroalcohol comprising reacting an aldehyde or a ketone and a nitroalkane in the presence of the chiral tetraaminophosphonium salt represented by formula (1) and a base, or in the presence of a conjugated base of the chiral tetraaminophosphonium salt represented by formula (1): wherein R1 to R4 are independently a hydrogen atom or a monovalent hydrocarbon group; and, R1 and R2 are different groups or R3 and R4 are different groups.

Abstract: The invention relates to novel ionic compounds with low risk of combustion, more particularly, ionic compounds represented by the general formula (I): (NPR12)n . . . (I) [wherein R1?s are each independently halogeno or a monovalent substituent and at least one of R1?s is a ionic substituent represented by the general formula (II): —N+R23X? . . . (II) (wherein R2?s are each independently a monovalent substituent or hydrogen, with the proviso that at least one of R2?s is not hydrogen, or R2?s may be united to form a ring; and X? is a monovalent anion); and n is 3 to 15].

Abstract: This invention relates to compounds which are N-oxides and derivatives thereof, as well as their use to treat HIF related diseases.

Abstract: Methods and compounds are provided for the formation of carbon-nitrogen or carbon-carbon bonds comprising reacting an amine or an aryl boronic acid with an aryl halide in the presence of a palladium catalyst, a base, and a compound of formula II:

Abstract: Novel cyclic phosphoramidate prodrugs of drugs of formula I their use in delivery of drugs to the liver, their use in enhancing oral bioavailability, and their method of preparation are described.

Abstract: Cyclic phosphazene compounds of formula (I): wherein: Q is a cyclic compound of formula: A is an end group of the —OCF2X, —OC2F4X, —OC3F6X type, wherein X=F, Cl, H; Rf and R?f are (per)fluoropolyoxyalkylene chains having a number average molecular weight in the range 280-5,000.